The sales of nervous system medicines in Germany are forecasted to grow steadily from 2024 to 2028, starting at $8.25 billion in 2024 and reaching $8.82 billion by 2028. Compared to 2023, where the actual sales stood at $8.11 billion, there is a positive growth trend. The year-on-year percentage change shows a consistent increase: 2025 by 1.82%, 2026 by 1.79%, 2027 by 1.64%, and 2028 by 1.50%. Over the five-year period, the compound annual growth rate (CAGR) is projected to be approximately 1.70%.

In the coming years, several trends are anticipated to shape the market:

Increased investment in research and development for innovative therapies.
Rising prevalence of neurological disorders and an aging population driving demand for medicines.
Regulatory changes and health policy adjustments influencing market dynamics.